Microneedling Contraindications Explained: The Complete Esthetician Safety Reference

Microneedling is one of the most results-driven treatments in the professional esthetic scope of practice — where permitted. The controlled micro-trauma it delivers initiates the skin’s natural wound-healing cascade, stimulating collagen and elastin production in ways that benefit a wide range of skin concerns from fine lines to acne scarring to overall texture refinement. Its effectiveness, however, is inseparable from the clinical judgment that precedes it.

Every esthetician who performs or is considering performing microneedling needs a comprehensive and current understanding of who this treatment is appropriate for — and who it categorically is not. The consequences of performing microneedling on a contraindicated client are not minor. Triggering a herpes outbreak across a freshly treated face, causing abnormal scarring in a keloid-prone client, or inducing excessive bleeding in someone on anticoagulant therapy are outcomes that cannot be undone in the treatment room. Prevention is the only protocol that matters.

This guide gives estheticians a structured, comprehensive reference for microneedling contraindications: what they are, why they matter, how to identify them during pre-treatment screening, and how to make informed decisions when the clinical picture is not straightforward. It also addresses the immediate post-treatment priorities for clients who have been safely cleared for the procedure.

Understanding the Two Categories: Absolute vs. Relative Contraindications

The distinction between absolute and relative contraindications is not semantic. It is a clinical framework that determines whether treatment should proceed at all, and if so, under what conditions. Every esthetician performing microneedling needs to understand both categories with clarity — and know exactly which conditions belong in each.

Absolute Contraindications: No Treatment, No Exceptions

An absolute contraindication means the risk of harm is so significant that no modification of technique, depth, or protocol can make the treatment safe. When an absolute contraindication is identified, the treatment is declined entirely until the condition resolves or medical clearance is obtained. There is no clinical judgment call to make. There is no “we can try a very shallow depth.” The answer is no, and the esthetician’s job in that moment is to explain the reason clearly, compassionately, and professionally.

Relative Contraindications: Evaluate Before Proceeding

A relative contraindication means there is a known risk factor present that elevates the probability of an adverse outcome. It does not automatically disqualify the client. It requires the esthetician to gather more information, consult with the client’s physician if warranted, consider protocol modifications such as reduced depth, avoided zones, or additional preparation, and document the decision process thoroughly. The clinical judgment to proceed with a relative contraindication present always carries professional responsibility. When in doubt, the default position should be to postpone and seek medical consultation rather than proceed and manage an adverse outcome.

Area-Specific Application

Most contraindications apply to the specific treatment area rather than the client’s body as a whole. A client with a history of keloid scarring only on their torso may not carry the same absolute risk to facial treatment as a client with keloid formation on the face itself. Area specificity requires thoughtful assessment — but never becomes a reason to dismiss a contraindication that does apply to the planned treatment zone.

Absolute Contraindications for Microneedling: The Full Reference List

Each of the following conditions represents an absolute contraindication when present in or directly adjacent to the planned treatment area. Treatment must not proceed until the condition has resolved and, where applicable, medical clearance has been obtained.

Why Active Acne Is an Absolute — Not a Relative — Contraindication

Estheticians occasionally encounter the question of whether shallow microneedling can be performed around or between active acne lesions. The answer is no, and the mechanism is straightforward. Microneedling creates micro-channels in the skin’s surface. In the presence of active inflammatory acne — which involves Cutibacterium acnes (formerly Propionibacterium acnes) bacteria within the follicle — those micro-channels can spread bacterial content laterally across the treatment surface. The mechanical disruption and pressure of the device passing over active lesions accelerates this spread into previously unaffected follicles. The outcome is not a worsening of existing spots; it is a new widespread breakout across the entire treatment area, often accompanied by post-inflammatory hyperpigmentation that can persist for months. Even a single cystic lesion in the treatment zone is sufficient to halt treatment.

Isotretinoin: Why the Waiting Period Is Not Negotiable

Isotretinoin operates systemically. It reduces sebaceous gland activity dramatically, decreasing sebum production by up to 90% in many users. Beyond its effects on oil production, isotretinoin alters the structure of the follicular epithelium, impairs fibroblast function, reduces wound healing capacity, and increases skin fragility and sensitization at the cellular level. These effects do not resolve the day the last pill is taken — they persist in tissue for months following the final dose. Microneedling on isotretinoin-altered skin creates a significantly elevated risk of abnormal wound healing, persistent erythema, scarring, and hyperpigmentation. The 6-month minimum waiting period is an evidence-based safety standard. Many dermatologists and microneedling specialists require 12 months before any CIT procedure is performed.

Keloid and Hypertrophic Scarring History

Keloid formation results from an abnormal fibroblastic response to skin injury, where collagen production continues beyond the boundaries of the original wound and does not self-terminate normally. Microneedling is, by definition, a wound-inducing procedure — the entire mechanism relies on triggering a wound healing response. In a client whose fibroblasts have demonstrated abnormal scar formation at any point in their history, that wound healing response cannot be predicted or controlled. This risk is not depth-dependent. Even 0.25mm superficial passes create controlled injury. Any esthetician who performs microneedling on a client with a confirmed keloid or hypertrophic scarring history assumes full responsibility for an outcome that may include permanent disfiguring scarring and significant client harm.

Relative Contraindications: What Requires Careful Evaluation Before Proceeding

Relative contraindications represent risk factors that deserve thorough assessment, documentation, and in many cases physician consultation. The decision to proceed in the presence of a relative contraindication should never be made casually. The threshold for obtaining medical consultation should be low — when in genuine uncertainty, that uncertainty itself is the signal to pause.

HSV History: The Antiviral Prerequisite

A client with a confirmed history of herpes simplex virus who presents without active lesions is not automatically disqualified from microneedling. However, the micro-trauma created by CIT is a well-documented trigger for HSV reactivation in susceptible individuals. The standard professional approach for clients with oral herpes (HSV-1) history involves requiring physician consultation and, in most cases, a prescription antiviral prophylaxis protocol initiated 24 to 48 hours before treatment and continued for 3 to 5 days post-procedure. Estheticians should never assume that the absence of an active lesion on the day of treatment means the client is HSV-negative — direct questioning about history is mandatory in every intake form.

Diabetes and Wound Healing Impairment

Diabetes mellitus — particularly Type 2 with poor glycemic control — is associated with impaired wound healing across multiple mechanisms: reduced fibroblast proliferation, diminished growth factor signaling, increased susceptibility to infection, and peripheral neuropathy that may mask discomfort indicators during treatment. Estheticians should require physician clearance before any microneedling procedure on a diabetic client, and should follow the most conservative possible protocol including reduced depth and enhanced post-treatment barrier support.

Medications That Affect Microneedling Safety: What to Ask and Why

Medications represent one of the most frequently missed contraindication categories in esthetic intake processes. Many clients do not connect their medications to their skin treatments — they assume “it’s just a facial” and do not mention prescriptions unless directly asked. Estheticians must ask specifically and systematically about all medications, not merely ask whether the client has any medical conditions.

Categories of Concern: Medications With Direct Impact on Microneedling Safety

Anticoagulants and blood thinners. Warfarin, heparin, rivaroxaban, apixaban, dabigatran, clopidogrel, and prescription aspirin therapy all impair normal coagulation. Even at the micro-injury level created by CIT, these medications can produce excessive bleeding, dramatic bruising, and delayed healing that are clinically unmanageable in an esthetic setting. These are absolute contraindications without exception.

Isotretinoin and systemic retinoids. Covered in detail in Section 2. The 6–12 month waiting period applies to all isotretinoin formulations and systemic retinoid equivalents, not just brand-name Accutane.

Immunosuppressants. Medications used in organ transplant protocols, chemotherapy agents, corticosteroids at immunosuppressive doses, and biologics used for autoimmune conditions all reduce the body’s normal immune response. This impairs both the wound healing response that microneedling depends on and the infection-defense mechanisms that protect against complications.

Topical retinoids. Tretinoin, adapalene, tazarotene, and prescription retinoid formulations accelerate cell turnover and thin the stratum corneum. Application in the days immediately before microneedling increases the risk of excessive penetration depth, irritation, and barrier compromise. Advise clients to discontinue all topical retinoids a minimum of 3 to 5 days before treatment.

Corticosteroids (topical at high potency). Prolonged use of high-potency topical steroids causes skin thinning (atrophy) and impairs barrier integrity. A client using Class I or II corticosteroids regularly in the planned treatment area should be evaluated carefully before any microneedling is performed.

NSAIDs. Non-steroidal anti-inflammatory drugs including over-the-counter ibuprofen and naproxen may increase bruising tendency. While not an absolute contraindication in the way that prescription blood thinners are, advising clients to avoid NSAIDs for 24 to 48 hours before treatment when it is medically appropriate to do so is standard professional practice.

How to Build a Pre-Treatment Screening Protocol That Catches Every Relevant Flag

A thorough contraindication screening process does not happen spontaneously during a conversation. It requires a structured intake form and a systematic verbal review process that covers the categories known to carry microneedling risk. Estheticians who rely on memory-based questioning or a generic health history form miss contraindications consistently. The following framework covers every required category.

• Skin Condition Visual and Verbal Audit

  Before any verbal intake begins, perform a direct visual assessment of the planned treatment zone under proper lighting. Identify active lesions, broken skin, visible infection signs, redness patterns, and dermatological conditions. Cross-reference what you see with what the client reports. Discrepancies between visual findings and intake form answers require direct follow-up questions.
• Complete Medication Review

  Ask specifically about every relevant medication category. Do not ask “are you on any medications?” and accept a vague yes or no. Ask about isotretinoin, blood thinners, immunosuppressants, retinoids, steroids, and antibiotics separately. Many clients do not identify over-the-counter aspirin or ibuprofen as “medications” without direct prompting.
• Medical History Documentation

  Your intake form must include fields for keloid and hypertrophic scarring history, autoimmune conditions, diabetes, bleeding or clotting disorders, skin cancer history, and any systemic conditions that affect healing or immunity. These must be updated at every appointment — not just at the initial consultation.
• Direct HSV History Question

  Ask every client directly: “Do you have a history of cold sores or herpes simplex virus on or around the area we are treating?” Many clients will not volunteer this information on a written form. Document the answer, record the date of last known outbreak, and require physician-prescribed prophylactic antivirals for any client who answers yes.
• Recent Procedure Timeline Review

  Ask about all procedures performed in the previous four to six weeks: laser treatments, medium to deep chemical peels, injectable neurotoxins and fillers, and other skin-disrupting procedures. Each of these has a required healing window before microneedling is appropriate.
• Pregnancy and Hormonal Status Confirmation

  Ask directly. Do not rely on the client to volunteer this information. Both pregnancy and active breastfeeding are absolute contraindications. Document the answer and include it in your signed consent form.
• Fitzpatrick Assessment and PIH Risk Evaluation

  Identify the client’s Fitzpatrick type and ask directly about any history of post-inflammatory hyperpigmentation. Skin types IV through VI carry elevated PIH risk with microneedling and require conservative depth settings, pre-treatment preparation protocols, and enhanced post-treatment care. This is addressed in detail in article M4.3.
• Informed Consent Review and Signature

  Every microneedling client must sign a procedure-specific informed consent form before every session. The form must disclose all known risks including infection, hyperpigmentation, scarring, herpes reactivation, and allergic reaction. A generic spa consent form does not meet this standard. Retain signed forms as part of your client records.

What Happens to the Skin After Microneedling and Why Recovery Protocol Matters

The contraindication screening process determines who receives the treatment. The post-treatment recovery protocol determines what happens to their skin immediately after. The two are inseparable components of a complete professional microneedling service.

The Post-CIT Skin State: Heightened Permeability and Compromised Barrier

Microneedling creates thousands of micro-channels in the skin’s surface per session. Immediately following treatment, transepidermal water loss (TEWL) increases dramatically as the physical barrier is temporarily compromised. The skin is in a state of heightened permeability — which means topically applied ingredients penetrate more deeply and more rapidly than they would on intact skin. This has two simultaneous implications. First, the window for delivering therapeutic hydrating agents such as hyaluronic acid and polyglutamic acid directly to the skin is maximized. Second, any ingredient with sensitizing potential — fragrance, active exfoliants, alcohol, or synthetic dyes — can produce heightened irritation, inflammation, and allergic response on the compromised surface.

The Three Post-CIT Skin Priorities

Barrier support. The physical integrity of the stratum corneum must be supported immediately post-procedure. An occlusive layer applied over the treatment surface reduces TEWL, provides a physical barrier against environmental exposure, and creates the contained microenvironment in which the skin’s healing response can proceed without additional external stressors.

Hydration delivery. The temporary channels created by microneedling represent a brief but significant window for humectant delivery to deeper skin layers than normal surface application reaches. Professional-grade humectants applied immediately post-treatment in an occlusive format are delivered into a highly receptive tissue environment. The combination of PGA and HA is particularly appropriate in this context: HA delivers moisture to the deeper skin layers through the open channels, while PGA seals the surface and inhibits the hyaluronidase activity that would otherwise accelerate degradation of both the applied and naturally occurring HA in the post-procedure skin.

Zero sensitizing ingredients. Post-microneedling skin is not in a state to tolerate fragrance, essential oils, acid actives, alcohol, artificial dyes, or any ingredient that carries sensitization potential on intact skin. On post-procedure skin with a temporarily compromised barrier, these ingredients can produce outcomes ranging from pronounced erythema to contact dermatitis to post-inflammatory hyperpigmentation. Fragrance-free, clean-label formulations are an absolute professional standard for post-CIT application — not a preference.

How to Professionally Decline a Microneedling Treatment When Contraindications Are Present

Identifying a contraindication is the clinical skill. Communicating the refusal professionally and compassionately is the client relationship skill. Both are necessary. Estheticians who have not rehearsed their language for declining a treatment often either over-explain in ways that feel accusatory, or under-explain in ways that feel dismissive. Neither outcome serves the client or the practice.

The Framework for a Professional Refusal Conversation

When you identify a contraindication that requires postponing or declining microneedling, the conversation should accomplish four things: explain clearly but simply why the treatment is not appropriate today, confirm what the client’s next step should be (resolve the condition, obtain medical clearance, wait the required period), offer what you can do instead to support the client’s skin goals in the current session, and document the contraindication, your decision, and the conversation in the client record.

For example, with active acne: “I can see some active breakouts in this area today, which means microneedling isn’t safe for you right now. If I needle over active spots, it can spread the bacteria and cause a much worse breakout across the whole face. Once these have fully cleared, we can rebook — typically 2 to 4 weeks. In the meantime, I can absolutely do a calming hydration facial today that will support your skin without any risk.”

For isotretinoin: “Because you finished Accutane within the last six months, your skin is still in a healing phase that makes microneedling too risky right now — it can cause scarring or slow healing. We need to wait until we’re at least six months out, and I’ll want to see a note from your dermatologist when we rebook. Let’s talk about what we can safely do for your skin in the meantime.”

What Belongs in the Client Record After a Refusal

Document the contraindication identified, the date of the consultation, the specific reason treatment was declined or postponed, what you advised the client to do, and any alternative service that was provided. This documentation is both a professional standard and a liability protection measure. Clients who later dispute a refusal, or who return having resolved the contraindication, need a clear record of the original consultation conversation.